Skip to main content
    C

    CEL-SCI Corp (CVM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.75
    +0.04 (+2.34%)

    Market Cap: $30.78M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    13%(3/24)
    Avg Surprise
    -163.73%
    Streak
    1 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 14
    		$-0.47N/AN/ABeat+79.8%
    Dec 25
    Reported Jan 12
    		$-0.68$0.00N/AMiss+74.8%
    Sep 25
    Reported Dec 23
    		$-0.86N/AN/ABeat+68.2%
    Jun 25
    Reported Aug 14
    		$-1.36N/AN/ABeat+67.6%
    Mar 25
    Reported May 14
    		$-2.33N/AN/ABeat+72.2%
    Dec 24
    Reported Jan 13
    		$-2.70$-3.30+18.18%Beat+35.7%
    Sep 24
    Reported Dec 31
    		$-2.70$-0.10-2600.30%Miss-1587.7%
    Jun 24
    Reported Aug 14
    		$-4.20$-3.90-7.69%Miss+26.3%
    Mar 24
    Reported May 16
    		$-8.40$-4.20-100.00%Miss-47.4%
    Dec 23
    Reported Feb 14
    		$-4.20$-4.20+0.00%Beat+22.2%
    Sep 23
    Reported Dec 22
    		$-0.16$-0.16+0.00%Beat+23.8%
    Jun 23
    Reported Aug 11
    		$-5.70$-4.50-26.67%Miss+17.4%
    Mar 23
    Reported May 12
    		$-5.70$-5.10-11.76%Miss+17.4%
    Dec 22
    Reported Feb 14
    		$-5.40$-3.00-80.00%Miss-2600.0%
    Sep 22
    Reported Dec 28
    		$-0.21$-0.20-5.00%Miss+96.3%
    Jun 22
    Reported Aug 15
    		$-6.90$-2.70-155.56%Miss-4.5%
    Mar 22
    Reported May 16
    		$-6.90$-2.70-155.56%Miss+17.9%
    Dec 21
    Reported Feb 14
    		$-0.20$-0.19-5.26%Miss+4.8%
    Sep 21
    Reported Dec 22
    		$-5.70$-3.00-90.00%Miss-35.7%
    Jun 21
    Reported Aug 16
    		$-6.60$-3.90-69.23%Miss+18.5%
    Mar 21
    Reported May 18
    		$-8.40$-5.70-47.37%Miss-12.0%
    Dec 20
    Reported Feb 16
    		$-0.21$-0.15-40.00%Miss-31.2%
    Sep 20
    Reported Dec 29
    		$-4.20$-3.00-40.00%Miss-7.7%
    Jun 20
    Reported Aug 11
    		$-8.10$-5.70-42.11%Miss+27.0%
    Mar 20
    Reported May 11
    		$-7.50$-4.50-66.67%Miss-3309.1%
    Dec 19
    Reported Feb 10
    		$-0.16$-0.15-6.67%Miss-500.0%
    Sep 19
    Reported Dec 16
    		$-3.90$-2.70-44.44%Miss-482.1%
    Jun 19
    Reported Aug 14
    		$-11.10$-3.00-270.00%Miss-2983.3%
    Mar 19
    Reported May 14
    		$-0.22$-0.12-83.33%Miss+29.0%
    Dec 18
    Reported Feb 14
    		$0.04N/AN/ABeat+107.5%
    Sep 18
    Reported Dec 20
    		$-0.67N/AN/ABeat-31.4%
    Jun 18
    Reported Aug 14
    		$-0.36N/AN/ABeat+32.1%
    Mar 18
    Reported May 15
    		$-0.31N/AN/ABeat+75.2%
    Dec 17
    Reported Feb 12
    		$-0.53N/AN/ABeat-312.0%
    Sep 17
    Reported Dec 29
    		$-0.51$0.00N/AMiss-
    Jun 17
    Reported Aug 9
    		$-0.53N/AN/ABeat-
    Mar 17
    Reported May 10
    		$-1.25N/AN/ABeat-
    Dec 16
    Reported Feb 9
    		$0.25N/AN/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-252.50%ROIC-109.01%
    Financial Health
    Debt/Equity0.47xInterest Coverage-50.19x
    Current Ratio1.48xQuick Ratio1.42x
    Trading Statistics
    Beta0.59Avg Volume277.98K
    52-Week High$10.1652-Week Low$0.89

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.05
    SMA 20$1.91
    SMA 50$1.69
    SMA 200$2.73
    EMA 10$1.89
    EMA 20$1.88
    EMA 50$1.74
    EMA 200$2.78

    MACD

    Line: 0.06Signal: 0.12Hist: -0.06

    ADX

    ADX: 37.7+DI: 25.1-DI: 17.9

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down8.0
    PSAR$2.54

    Bollinger Bands

    Upper Band$2.51
    Lower Band$1.32
    %B Position6219%(Upper)
    Band Width0.36

    RSI (14-Day)

    Neutral
    47.0

    Momentum Oscillators

    Stoch %K6.3
    Stoch %D10.0
    Williams %R-92.3
    ROC (10d)-16.3%
    Momentum-0.34
    CCI (20d)-53.5
    MFI (14d)64.0

    Volatility Measures

    ATR (14d)$0.20(11.4%)
    StdDev (20d)0.30
    Hist Vol132.4%(High)

    Volume Flow

    VWAP$1.73
    OBV-35.3M
    AD Line17.5B
    CMF (20d)-0.082

    Volume Metrics

    Avg Vol (20d)300.0K
    Vol Ratio0.2x(Low)
    VWMA (20d)$2.08

    Pivot Points

    R3$1.82
    R2$1.78
    R1$1.75
    Pivot Point$1.71
    S1$1.68
    S2$1.64
    S3$1.61

    Advanced Oscillators

    TSI8.53
    Ultimate Osc34.5
    KST295.66

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0$0$960,850$0$0$0N/A$0$0$0$998,653
    Gross Profit$0$0$0$-960,850$0$0$0N/A$0$0$0$-998,653
    Operating Expenses$5.56M$5.33M$5.37M$6.03M$5.49M$6.39M$6.89M$6.12M$6.67M$7.08M$6.49M$7.47M
    R&D$3.65M$3.77M$3.68M$3.70M$3.74M$4.01M$4.43M$4.48M$4.70M$4.63M$4.35M$5.27M
    SG&A$1.91M$1.56M$1.69M$2.33M$1.75M$2.38M$2.46M$1.64M$1.97M$2.45M$2.13M$2.20M
    Operating Income$-5,557,285$-5,326,009$-5,368,806$-6,033,332$-5,488,883$-6,394,103$-6,893,418$-6,120,404$-6,670,235$-7,075,948$-6,485,887$-7,467,522
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$110,240$117,485$87,789$128,505$172,050$178,286$170,103$174,571$190,705$182,701$197,696$500,020
    Income Before Tax$-5,667,525$-5,443,494$-5,456,595$-6,161,837$-5,660,933$-6,572,389$-7,063,521$-6,308,733$-6,860,940$-7,244,891$-6,683,583$-7,963,688
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-5,667,525$-5,465,751$-5,469,446$-6,100,900$-5,664,704$-6,572,389$-7,073,062$-6,109,492$-6,856,558$-7,244,891$-6,709,524$-7,630,704
    EBITDA$-4,610,915$-4,369,608$-4,404,384$-5,072,482$-4,529,874$-5,424,001$-5,898,226$-5,128,824$-5,686,027$-6,073,428$-5,481,254$-6,468,869
    EBIT$-5,557,285$-5,326,009$-5,368,806$-6,033,332$-5,488,883$-6,394,103$-6,893,418$-6,120,404$-6,670,235$-7,062,190$-6,485,887$-7,467,522
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CVM

    News

    CEL SCI Corp CSO Eyal Talor Purchases 1,165 Shares of Common Stock

    CEL SCI Corp's Chief Scientific Officer, Eyal Talor, acquired 1,165 shares of common stock on September 30, 2026...

    Kalkine Media•10/1/26•Somewhat-Bullish

    Form 4 CEL-SCI Corp For: 1 October By Investing.com

    This article from Investing.com reports on a Form 4 filing for CEL-SCI Corp (CVM) on October 1st. The brief entry provides the company's stock symbol and its recent price performance. It is a concise news item indicating...

    Investing.com Australia•10/1/26•Neutral

    A 2,082-share award brings CEL SCI CORP (CVM) CFO Patricia B. Prichep's direct holding to 19,571 shares.

    CEL SCI CORP CFO Patricia B. Prichep received a grant of 2,082 common shares on September 30, 2026, valued at $2.06 per share. This transaction increased her direct holding to 19,571 shares. The acquisition was...

    Stock Titan•10/1/26•Neutral

    A 2,621-share grant leaves CEL SCI CORP (CVM) CEO holding 318,763 shares directly.

    CEL SCI CORP CEO Geert R. Kersten received a grant of 2,621 shares of Common Stock on September 30, 2026, priced at $2.06 per share. Following this transaction...

    Stock Titan•10/1/26•Neutral

    A 1,165-share award brings Eyal Talor’s direct CEL SCI CORP (CVM) holdings to 10,483 shares.

    CEL SCI CORP's Chief Scientific Officer, Eyal Talor, received an award of 1,165 common shares on September 30, 2026...

    Stock Titan•10/1/26•Neutral

    CVM Valuation and Fair Value

    Forward P/E
    23.0x
    PEG
    1.1x
    P/B
    2.8x
    See GNG's fair value

    CVM Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -109.0%
    ROE
    -252.5%

    CVM Competitors

    CompanyTicker
    Rockwell Medical IncRMTI
    Milestone ScientificMLSS
    Briacell Therapeutics CorpBCTX
    Actinium Pharmaceuticals IncATNM
    Quince Therapeutics, Inc.QNCX
    Barinthus Biotherapeutics plcBRNS
    China Pharma Holdings IncCPHI
    DocGo IncDCGO

    Sector: Healthcare

    CVM Bull Case vs Bear Case

    Bear case

    • CVM beat EPS estimates in 12.5% of its last 8 reported quarters.
    • CVM's quarterly revenue changed -62.7% year over year.

    CVM Earnings: Beat Rate and Next Report

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -388.1%

    Frequently Asked Questions About CVM

    Does CVM pay dividends?

    CEL-SCI Corp (CVM) does not currently pay a regular dividend.

    What is CVM's market cap?

    CEL-SCI Corp (CVM) has a market capitalization of $30.78M with a current stock price of $1.75.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In